{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T03:00:01Z","timestamp":1787108401411,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41375-025-02731-2","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T06:48:58Z","timestamp":1756190938000},"page":"2673-2685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Retinoic acid disrupts an NPM1c\/ROS\/SENP3\/ARF oncogenic axis in acute myeloid leukemia"],"prefix":"10.1038","volume":"39","author":[{"given":"Rita","family":"Hleihel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Skayneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Chieh","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maguy","family":"Hamie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8321-4025","authenticated-orcid":false,"given":"Abdallah","family":"Kurdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Dakour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9157-7208","authenticated-orcid":false,"given":"Charbel","family":"Machaalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"El-Sabban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1113-4472","authenticated-orcid":false,"given":"Hugues","family":"de Th\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7171-4997","authenticated-orcid":false,"given":"Ali","family":"Bazarbachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1069-0477","authenticated-orcid":false,"given":"Hiba","family":"El Hajj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"2731_CR1","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1038\/leu.2009.124","volume":"23","author":"B Falini","year":"2009","unstructured":"Falini B, Bolli N, Liso A, Martelli M, Mannucci R, Pileri S, et al. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. Leukemia. 2009;23:1731\u201343.","journal-title":"Leukemia"},{"key":"2731_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1242\/jcs.01736","volume":"118","author":"YW Lam","year":"2005","unstructured":"Lam YW, Trinkle-Mulcahy L, Lamond AI. The nucleolus. J Cell Sci. 2005;118:1335\u20137.","journal-title":"J Cell Sci"},{"key":"2731_CR3","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1182\/blood-2010-08-299990","volume":"117","author":"B Falini","year":"2011","unstructured":"Falini B, Martelli MP, Bolli N, Sportoletti P, Liso A, Tiacci E, et al. Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?. Blood. 2011;117:1109\u201320.","journal-title":"Blood"},{"key":"2731_CR4","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1182\/blood.2019004226","volume":"136","author":"B Falini","year":"2020","unstructured":"Falini B, Brunetti L, Sportoletti P, Martelli MP. NPM1-mutated acute myeloid leukemia: from bench to bedside. Blood. 2020;136:1707\u201321.","journal-title":"Blood"},{"key":"2731_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nature03915","volume":"437","author":"S Grisendi","year":"2005","unstructured":"Grisendi S, Bernardi R, Rossi M, Cheng K, Khandker L, Manova K, et al. Role of nucleophosmin in embryonic development and tumorigenesis. Nature. 2005;437:147\u201353.","journal-title":"Nature"},{"key":"2731_CR6","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S1097-2765(03)00431-3","volume":"12","author":"K Itahana","year":"2003","unstructured":"Itahana K, Bhat KP, Jin A, Itahana Y, Hawke D, Kobayashi R, et al. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol Cell. 2003;12:1151\u201364.","journal-title":"Mol Cell"},{"key":"2731_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/embor.2008.3","volume":"9","author":"M Haindl","year":"2008","unstructured":"Haindl M, Harasim T, Eick D, Muller S. The nucleolar SUMO-specific protease SENP3 reverses SUMO modification of nucleophosmin and is required for rRNA processing. EMBO Rep. 2008;9:273\u20139.","journal-title":"EMBO Rep"},{"key":"2731_CR8","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.tibs.2007.05.002","volume":"32","author":"D Mukhopadhyay","year":"2007","unstructured":"Mukhopadhyay D, Dasso M. Modification in reverse: the SUMO proteases. Trends Biochem Sci. 2007;32:286\u201395.","journal-title":"Trends Biochem Sci"},{"key":"2731_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMoa041974","volume":"352","author":"B Falini","year":"2005","unstructured":"Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L, et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med. 2005;352:254\u201366.","journal-title":"N Engl J Med"},{"key":"2731_CR10","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H Dohner","year":"2022","unstructured":"Dohner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345\u201377.","journal-title":"Blood"},{"key":"2731_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1158\/2643-3230.BCD-23-0144","volume":"5","author":"B Falini","year":"2024","unstructured":"Falini B, Dillon R. Criteria for diagnosis and molecular monitoring of NPM1-mutated AML. Blood Cancer Discov. 2024;5:8\u201320.","journal-title":"Blood Cancer Discov"},{"key":"2731_CR12","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022;36:1703\u201319.","journal-title":"Leukemia"},{"key":"2731_CR13","doi-asserted-by":"publisher","first-page":"6230","DOI":"10.1158\/0008-5472.CAN-07-0273","volume":"67","author":"N Bolli","year":"2007","unstructured":"Bolli N, Nicoletti I, De Marco MF, Bigerna B, Pucciarini A, Mannucci R, et al. Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants. Cancer Res. 2007;67:6230\u20137.","journal-title":"Cancer Res"},{"key":"2731_CR14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ccell.2018.08.005","volume":"34","author":"L Brunetti","year":"2018","unstructured":"Brunetti L, Gundry MC, Sorcini D, Guzman AG, Huang YH, Ramabadran R, et al. Mutant NPM1 maintains the leukemic state through HOX expression. Cancer Cell. 2018;34:499\u2013512.e9.","journal-title":"Cancer Cell"},{"key":"2731_CR15","doi-asserted-by":"crossref","unstructured":"Wu HC, Rerolle D, Berthier C, Hleihel R, Sakamoto T, Quentin S, et al. Actinomycin D targets NPM1c-primed mitochondria to restore PML-driven senescence in AML therapy. Cancer Discov. 2021;11:3198\u2013213.","DOI":"10.1158\/2159-8290.CD-21-0177"},{"key":"2731_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nrc.2017.103","volume":"18","author":"H de The","year":"2018","unstructured":"de The H. Differentiation therapy revisited. Nat Rev Cancer. 2018;18:117\u201327.","journal-title":"Nat Rev Cancer"},{"key":"2731_CR17","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ccell.2017.10.002","volume":"32","author":"H de The","year":"2017","unstructured":"de The H, Pandolfi PP, Chen Z. Acute promyelocytic leukemia: a paradigm for oncoprotein-targeted cure. Cancer Cell. 2017;32:552\u201360.","journal-title":"Cancer Cell"},{"key":"2731_CR18","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1182\/blood-2009-08-236588","volume":"115","author":"AK Burnett","year":"2010","unstructured":"Burnett AK, Hills RK, Green C, Jenkinson S, Koo K, Patel Y, et al. The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA. Blood. 2010;115:948\u201356.","journal-title":"Blood"},{"key":"2731_CR19","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1038\/sj.leu.2403528","volume":"18","author":"RF Schlenk","year":"2004","unstructured":"Schlenk RF, Frohling S, Hartmann F, Fischer JT, Glasmacher A, del Valle F, et al. Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia. Leukemia. 2004;18:1798\u2013803.","journal-title":"Leukemia"},{"key":"2731_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109878","volume":"125","author":"Y Cao","year":"2020","unstructured":"Cao Y, Liu Y, Shang L, Wei W, Shen Y, Gu Q, et al. Decitabine and all-trans retinoic acid synergistically exhibit cytotoxicity against elderly AML patients via miR-34a\/MYCN axis. Biomed Pharmacother. 2020;125:109878.","journal-title":"Biomed Pharmacother"},{"key":"2731_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1200\/JCO.19.01053","volume":"38","author":"M L\u00fcbbert","year":"2020","unstructured":"L\u00fcbbert M, Grishina O, Schmoor C, Schlenk RF, Jost E, Crysandt M, et al. Valproate and retinoic acid in combination with decitabine in elderly nonfit patients with acute myeloid leukemia: results of a multicenter, randomized, 2 \u00d7 2, phase II trial. J Clin Oncol. 2020;38:257\u201370.","journal-title":"J Clin Oncol"},{"key":"2731_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3324\/haematol.13378","volume":"94","author":"RF Schlenk","year":"2009","unstructured":"Schlenk RF, D\u00f6hner K, Kneba M, G\u00f6tze K, Hartmann F, Del Valle F, et al. Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B. Haematologica. 2009;94:54\u201360.","journal-title":"Haematologica"},{"key":"2731_CR23","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1182\/blood-2014-11-612416","volume":"125","author":"H El Hajj","year":"2015","unstructured":"El Hajj H, Dassouki Z, Berthier C, Raffoux E, Ades L, Legrand O, et al. Retinoic acid and arsenic trioxide trigger degradation of mutated NPM1, resulting in apoptosis of AML cells. Blood. 2015;125:3447\u201354.","journal-title":"Blood"},{"key":"2731_CR24","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1182\/blood-2014-11-611459","volume":"125","author":"MP Martelli","year":"2015","unstructured":"Martelli MP, Gionfriddo I, Mezzasoma F, Milano F, Pierangeli S, Mulas F, et al. Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells. Blood. 2015;125:3455\u201365.","journal-title":"Blood"},{"key":"2731_CR25","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.3324\/haematol.2020.274878","volume":"106","author":"R Hleihel","year":"2021","unstructured":"Hleihel R, El Hajj H, Wu HC, Berthier C, Zhu HH, Massoud R, et al. A Pin1\/PML\/P53 axis activated by retinoic acid in NPM1c acute myeloid leukemia. Haematologica. 2021;106:3090\u20139.","journal-title":"Haematologica"},{"key":"2731_CR26","doi-asserted-by":"crossref","unstructured":"Skayneh H, Jishi B, Hleihel R, Hamie M, El Hajj R, Deleuze-Masquefa C, et al. EAPB0503, an imidazoquinoxaline derivative modulates SENP3\/ARF mediated SUMOylation, and induces NPM1c degradation in NPM1 mutant AML. Int J Mol Sci. 2022;23:3421.","DOI":"10.3390\/ijms23073421"},{"key":"2731_CR27","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1038\/emboj.2010.245","volume":"29","author":"S Yan","year":"2010","unstructured":"Yan S, Sun X, Xiang B, Cang H, Kang X, Chen Y, et al. Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90. EMBO J. 2010;29:3773\u201386.","journal-title":"EMBO J"},{"key":"2731_CR28","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1172\/JCI62129","volume":"122","author":"A Carracedo","year":"2012","unstructured":"Carracedo A, Weiss D, Leliaert AK, Bhasin M, de Boer VC, Laurent G, et al. A metabolic prosurvival role for PML in breast cancer. J Clin Invest. 2012;122:3088\u2013100.","journal-title":"J Clin Invest"},{"key":"2731_CR29","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1084\/jem.20150736","volume":"213","author":"H Boutzen","year":"2016","unstructured":"Boutzen H, Saland E, Larrue C, de Toni F, Gales L, Castelli FA, et al. Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia. J Exp Med. 2016;213:483\u201397.","journal-title":"J Exp Med"},{"key":"2731_CR30","doi-asserted-by":"publisher","first-page":"8754","DOI":"10.1158\/0008-5472.CAN-04-3569","volume":"65","author":"L Altucci","year":"2005","unstructured":"Altucci L, Rossin A, Hirsch O, Nebbioso A, Vitoux D, Wilhelm E, et al. Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptor. Cancer Res. 2005;65:8754\u201365.","journal-title":"Cancer Res"},{"key":"2731_CR31","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.3324\/haematol.2018.192807","volume":"104","author":"MR McKeown","year":"2019","unstructured":"McKeown MR, Johannessen L, Lee E, Fiore C, di Tomaso E. Antitumor synergy with SY-1425, a selective RARalpha agonist, and hypomethylating agents in retinoic acid receptor pathway activated models of acute myeloid leukemia. Haematologica. 2019;104:e138\u2013e42.","journal-title":"Haematologica"},{"key":"2731_CR32","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1038\/leu.2013.222","volume":"27","author":"M Huang","year":"2013","unstructured":"Huang M, Thomas D, Li MX, Feng W, Chan SM, Majeti R, et al. Role of cysteine 288 in nucleophosmin cytoplasmic mutations: sensitization to toxicity induced by arsenic trioxide and bortezomib. Leukemia. 2013;27:1970\u201380.","journal-title":"Leukemia"},{"key":"2731_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.blre.2017.11.001","volume":"32","author":"P Kunchala","year":"2018","unstructured":"Kunchala P, Kuravi S, Jensen R, McGuirk J, Balusu R. When the good go bad: Mutant NPM1 in acute myeloid leukemia. Blood Rev. 2018;32:167\u201383.","journal-title":"Blood Rev"},{"key":"2731_CR34","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1172\/JCI97117","volume":"128","author":"X Gu","year":"2018","unstructured":"Gu X, Ebrahem Q, Mahfouz RZ, Hasipek M, Enane F, Radivoyevitch T, et al. Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates. J Clin Invest. 2018;128:4260\u201379.","journal-title":"J Clin Invest"},{"key":"2731_CR35","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.4161\/cc.7.21.6930","volume":"7","author":"ML Kuo","year":"2008","unstructured":"Kuo ML, den Besten W, Thomas MC, Sherr CJ. Arf-induced turnover of the nucleolar nucleophosmin-associated SUMO-2\/3 protease Senp3. Cell Cycle. 2008;7:3378\u201387.","journal-title":"Cell Cycle"},{"key":"2731_CR36","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1083\/jcb.200807185","volume":"183","author":"C Yun","year":"2008","unstructured":"Yun C, Wang Y, Mukhopadhyay D, Backlund P, Kolli N, Yergey A, et al. Nucleolar protein B23\/nucleophosmin regulates the vertebrate SUMO pathway through SENP3 and SENP5 proteases. J Cell Biol. 2008;183:589\u201395.","journal-title":"J Cell Biol"},{"key":"2731_CR37","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1182\/blood-2014-04-572750","volume":"125","author":"Z Dassouki","year":"2015","unstructured":"Dassouki Z, Sahin U, El Hajj H, Jollivet F, Kfoury Y, Lallemand-Breitenbach V, et al. ATL response to arsenic\/interferon therapy is triggered by SUMO\/PML\/RNF4-dependent Tax degradation. Blood. 2015;125:474\u201382.","journal-title":"Blood"},{"key":"2731_CR38","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/ncb1717","volume":"10","author":"V Lallemand-Breitenbach","year":"2008","unstructured":"Lallemand-Breitenbach V, Jeanne M, Benhenda S, Nasr R, Lei M, Peres L, et al. Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4\/ubiquitin-mediated pathway. Nat Cell Biol. 2008;10:547\u201355.","journal-title":"Nat Cell Biol"},{"key":"2731_CR39","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1096\/fj.09-142281","volume":"24","author":"R Acin-Perez","year":"2010","unstructured":"Acin-Perez R, Hoyos B, Zhao F, Vinogradov V, Fischman DA, Harris RA, et al. Control of oxidative phosphorylation by vitamin A illuminates a fundamental role in mitochondrial energy homoeostasis. FASEB J. 2010;24:627\u201336.","journal-title":"FASEB J"},{"key":"2731_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11926-y","volume":"10","author":"K Nohara","year":"2019","unstructured":"Nohara K, Mallampalli V, Nemkov T, Wirianto M, Yang J, Ye Y, et al. Nobiletin fortifies mitochondrial respiration in skeletal muscle to promote healthy aging against metabolic challenge. Nat Commun. 2019;10:3923.","journal-title":"Nat Commun"},{"key":"2731_CR41","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","volume":"22","author":"EC Cheung","year":"2022","unstructured":"Cheung EC, Vousden KH. The role of ROS in tumour development and progression. Nat Rev Cancer. 2022;22:280\u201397.","journal-title":"Nat Rev Cancer"},{"key":"2731_CR42","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019;37:907\u201315.","journal-title":"Nat Biotechnol"},{"key":"2731_CR43","doi-asserted-by":"crossref","unstructured":"Danecek P, Bonfield JK, Liddle J, Marshall J, Ohan V, Pollard MO, et al. Twelve years of SAMtools and BCFtools. Gigascience. 2021;10:giab008.","DOI":"10.1093\/gigascience\/giab008"},{"key":"2731_CR44","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923\u201330.","journal-title":"Bioinformatics"},{"key":"2731_CR45","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02731-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02731-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02731-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:03:54Z","timestamp":1762337034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02731-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2731"],"URL":"https:\/\/doi.org\/10.1038\/s41375-025-02731-2","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}